Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event-Reference-Cited by-同舟云学术

Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event

Published:2023-12-09 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Sztejkowski Cédric¹²,Sibilia Jean¹²³,Danion François³⁴,Mertz Philippe¹²,Elodie Fels¹²,Kassegne Loïc⁵,Boyer Pierre⁶,Puéchal Xavier⁷⁸^ORCID,Gottenberg Jacques-Eric¹²,Scherlinger Marc¹²³^ORCID

Affiliation:

1. Centre National de Référence des Maladies Auto-Immunes et Systémiques Rares, Est/Sud-Ouest (RESO) , Strasbourg, France

2. Service de Rhumatologie, Centre Hospitalier Universitaire de Strasbourg , Strasbourg, France

3. Laboratoire d’ImmunoRhumatologie Moléculaire, Institut National de la Santé et de la Recherche médicale (INSERM) UMR_S 1109 , Strasbourg, France

4. Service de Maladie Infectieuse, Centre Hospitalier Universitaire de Strasbourg, quai Louis Pasteur , Strasbourg, France

5. Service de Pneumologie, Pôle de Pathologie Thoracique, Centre Hospitalier Universitaire de Strasbourg, quai Louis Pasteur , Strasbourg, France

6. Institut de Bactériologie, Centre Hospitalier Universitaire de Strasbourg, quai Louis Pasteur , Strasbourg, France

7. Centre de Référence des Maladies Auto-Immunes et Systémiques Rares d’Ile de France , Paris, France

8. Service de Médecine Interne, Hôpital Cochin APHP Centre , Paris, France

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kead672/54942580/kead672.pdf

Reference6 articles.

1. EULAR definition of difficult-to-treat rheumatoid arthritis;Nagy;Ann Rheum Dis,2021

2. Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases);Gottenberg;RMD Open,2022

3. Systematic review: whipple’s disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors;Marth;Aliment Pharmacol Ther,2015

4. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center;Lagier;Medicine (Baltimore),2010

5. Whipple’s disease;Puéchal;Ann Rheum Dis,2013